Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease.
Isabel M Cornejo-ParejaAna María Gómez-PérezJosé Carlos Fernández-GarcíaRebeca Barahona San MillanAlexandre Aguilera LuqueAna de HollandaAmanda JiménezSusana Jimenez-MurciaLucero MunguiaEmilio OrtegaFernando Fernandez-ArandaJosé M Fernández RealFrancisco TinahonesPublished in: European eating disorders review : the journal of the Eating Disorders Association (2020)
The COVID-19 pandemic is posing a great challenge worldwide. Its rapid progression has caused thousands of deaths worldwide. Although multiple aspects remain to be clarified, some risk factors associated with a worse prognosis have been identified. These include obesity and some of its main complications, such as diabetes and high blood pressure. Furthermore, although the possible long-term complications and psychological effects that may appear in survivors of COVID-19 are not well known yet, there is a concern that those complications may be greater in obese patients. In this manuscript, we review some of the data published so far and the main points that remain to be elucidated are emphasized.
Keyphrases
- coronavirus disease
- weight loss
- type diabetes
- obese patients
- insulin resistance
- metabolic syndrome
- bariatric surgery
- high fat diet induced
- blood pressure
- sars cov
- weight gain
- risk factors
- roux en y gastric bypass
- respiratory syndrome coronavirus
- gastric bypass
- cardiovascular disease
- glycemic control
- adipose tissue
- big data
- randomized controlled trial